Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
Merck
MRK
|
+$921M |
| 2 |
Union Pacific
UNP
|
+$581M |
| 3 |
Salesforce
CRM
|
+$417M |
| 4 |
Edwards Lifesciences
EW
|
+$409M |
| 5 |
ServiceNow
NOW
|
+$316M |
Top Sells
| 1 |
Caterpillar
CAT
|
+$664M |
| 2 |
RHT
Red Hat Inc
RHT
|
+$632M |
| 3 |
Texas Instruments
TXN
|
+$571M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$540M |
| 5 |
Parker-Hannifin
PH
|
+$513M |
Sector Composition
| 1 | Technology | 21.1% |
| 2 | Healthcare | 17.5% |
| 3 | Consumer Discretionary | 17.06% |
| 4 | Financials | 12.7% |
| 5 | Communication Services | 11.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
426
Range Resources
RRC
$8.3B
| $10.6M | 0.01% |
1,103,618
-162,001
| -13% | -$1.55M |
|
|
SYNH
427
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $10.5M | 0.01% |
267,738
+1,622
| +0.6% | +$63.8K |
|
428
Bank OZK
OZK
$5.89B
| $10.5M | 0.01% |
461,282
-1,190,816
| -72% | -$27.2M |
|
|
EQM
429
DELISTED
EQM Midstream Partners, LP
EQM
| $10.5M | 0.01% |
242,464
-11,360
| -4% | -$491K |
|
430
Bandwidth Inc
BAND
$458M
| $10.4M | 0.01% |
+255,359
| New | +$10.4M |
|
431
National Vision
EYE
$1.79B
| $10.3M | 0.01% |
+363,980
| New | +$10.3M |
|
|
BPMC
432
DELISTED
Blueprint Medicines
BPMC
| $10.1M | 0.01% |
187,849
-34,691
| -16% | -$1.87M |
|
433
Spyre Therapeutics
SYRE
$977M
| $10.1M | 0.01% |
54,072
-7,224
| -12% | -$1.35M |
|
434
Freeport-McMoran
FCX
$64.4B
| $9.97M | 0.01% |
967,152
-95,685
| -9% | -$986K |
|
|
PARA
435
DELISTED
Paramount Global Class B
PARA
| $9.91M | 0.01% |
226,649
-5,989
| -3% | -$262K |
|
436
XPO
XPO
$15.3B
| $9.86M | 0.01% |
499,893
-1,642,300
| -77% | -$32.4M |
|
437
ProPetro Holding
PUMP
$505M
| $9.72M | 0.01% |
788,642
-146,271
| -16% | -$1.8M |
|
|
FOCS
438
DELISTED
Focus Financial Partners Inc. Class A
FOCS
| $9.54M | 0.01% |
362,325
+1,457
| +0.4% | +$38.4K |
|
439
Sunrun
RUN
$3.74B
| $9.5M | 0.01% |
872,429
+18,388
| +2% | +$200K |
|
440
Western Midstream Partners
WES
$14.6B
| $9.5M | 0.01% |
342,485
-16,048
| -4% | -$445K |
|
|
AIMT
441
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $9.29M | 0.01% |
388,458
-44,518
| -10% | -$1.06M |
|
442
BrightView Holdings
BV
$1.31B
| $9.06M | 0.01% |
887,281
-24,898
| -3% | -$254K |
|
443
Agios Pharmaceuticals
AGIO
$2.07B
| $8.92M | 0.01% |
193,531
-1,839
| -0.9% | -$84.8K |
|
444
Thermon Group Holdings
THR
$826M
| $8.87M | 0.01% |
+437,132
| New | +$8.87M |
|
445
Patterson-UTI
PTEN
$2.11B
| $8.83M | 0.01% |
853,016
-445,836
| -34% | -$4.61M |
|
446
Steel Dynamics
STLD
$19.5B
| $8.81M | 0.01% |
293,161
-164,820
| -36% | -$4.95M |
|
|
GSKY
447
DELISTED
GreenSky, Inc. Class A Common Stock
GSKY
| $8.75M | 0.01% |
913,990
+162,280
| +22% | +$1.55M |
|
448
Douglas Emmett
DEI
$2.75B
| $8.74M | 0.01% |
+255,947
| New | +$8.74M |
|
449
Diageo
DEO
$57.9B
| $8.64M | 0.01% |
60,898
-88,967
| -59% | -$12.6M |
|
|
ARYAU
450
DELISTED
ARYA Sciences Acquisiton Corp. Unit
ARYAU
| $8.49M | 0.01% |
+829,513
| New | +$8.49M |
|